drugset / Trial / NCT00355589

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

NCT00355589

Phase 3 Completed Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.

Timeline

Start
2006-07
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Subject Ramipril Small molecule 10 mg
Subject Ramipril Small molecule 20 mg